You are here

vaccines

Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial

Motley Fool

Fri, 01/15/21 - 09:44 am

Moderna Therapeutics

clinical trials

Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up

Fierce Biotech

Fri, 01/15/21 - 09:43 am

Former FDA chief David Kessler will helm Operation Warp Speed for Biden

Stat

Fri, 01/15/21 - 09:41 am

Operation Warp Speed

Biden requests $415 billion from Congress to ramp up the country’s Covid-19 response

Stat

Thu, 01/14/21 - 10:35 pm

contact tracing

Vaccine registration technology is failing. Here’s how the Biden administration could fix it

Stat

Thu, 01/14/21 - 11:15 am

IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines

Fierce Biotech

Thu, 01/14/21 - 11:02 am

cancer vaccines

clinical trials

Biotech startup raises $25M for cancer, Covid-19 vaccines

MedCity News

Thu, 01/14/21 - 10:42 am

Aivita Biomedical

cancer vaccines

Johnson & Johnson Expects Vaccine Results Soon but Lags in Production

NY Times, NY

Thu, 01/14/21 - 10:33 am

JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says

Fierce Pharma

Wed, 01/13/21 - 11:41 pm

drug manufacturing

Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up

Stat

Wed, 01/13/21 - 11:39 pm

clinical trials

JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

Fierce Biotech

Wed, 01/13/21 - 10:53 am

Moncef Slaoui to step down from Operation Warp Speed in a month — report

Endpoints

Wed, 01/13/21 - 10:38 am

Operation Warp Speed

Moderna and Uber Teaming Up on Coronavirus Vaccine Awareness Push

Motley Fool

Wed, 01/13/21 - 12:10 am

Moderna Therapeutics

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Pharmaforum

Wed, 01/13/21 - 12:08 am

JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say

Fierce Pharma

Tue, 01/12/21 - 11:13 am

Key takeaways from BioNTech CEO’s JPM presentation

MedCity News

Tue, 01/12/21 - 11:05 am

Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA

Endpoints

Tue, 01/12/21 - 10:59 am

pneumococcal disease

priority review

JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data

Fierce Pharma

Tue, 01/12/21 - 10:57 am

clinical trials

Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?

Motley Fool

Mon, 01/11/21 - 10:33 am

clinical trials

Moderna to run three new infectious disease vaccine development programs, EU vaccine distribution begins

Biopharma Reporter

Mon, 01/11/21 - 10:27 am

Moderna Therapeutics

infectious diseases

Pages